Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-01-26
2000-10-17
Seaman, D. Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 95, C07D45506, A61K 3144
Patent
active
061332836
ABSTRACT:
To provide novel compounds relating to retinoid which can substitute for retinoic acid used for preventing and treating several diseases and having antagonism against retinoid. Heterocyclic compounds represented by the general formula (1-I) or physiologically acceptable salts thereof:
REFERENCES:
patent: 4894386 (1990-01-01), Brown
patent: 4977276 (1990-12-01), Berlin
patent: 5039684 (1991-08-01), Bernareggi
Chemical Abstracts 119:160674, Cai, 1993.
Silhankova, Collection Czech Chem Comm, vol. 43, pp. 1484-87, 1978.
Stokker, Heterocycles, vol. 26(3), pp. 157-162, 1987.
Keidel, Molecular and Celluar Biology, vol. 14(1) 1/94, pp. 287-298.
Cal, J. Am. Chem. Soc., vol. 115, pp. 7192-7198, 1993.
Robinson, Tetrahedron, vol. 46(2), pp. 335-340, 1990.
Makosa, Synthesis, pp. 1142-1144, 1987.
Varga, Molecular Immunology, vol. 28(6), pp. 641-654, 1991.
Sunthankar, J of Phamaceutical Sciences, vol. 82(5), pp. 543-546, 1993.
Chemical Abstracts 124:261073, 1996.
Chemical Abstracts 121:180227, 1993.
Chemical Abstracts 118:191764, 1992.
Chemical Abstracts 115:208082, 1991.
Chemical Abstracts 112:158233, 1989.
Chemical Abstracts 102:220710, 1985.
Crettaz et al Biochem J. (1990) 272, 391-397 "Ligand specificities of recombinant retinoic acid receptors RAR.alpha. and RAR.beta.".
Sani et al Archives of Biochemistry and Biophysics vol. 283, No. 1, Nov. 15, 1990 pp. 107-113 "Isolation, Partial Purification and Characterization of Nuclear Retinoic Acid Receptors from Chick Skin".
Niculescu-Duvaz et al Carcinogenisis vol. 6, No. 4, pp. 479-486 1985 "QSAR application in chemical carcinogenisis. II. QSAR analysis of a class of carcinogenesis inhibitor: retinoids".
Abe Shinya
Asada Makoto
Hibi Shigeki
Hida Takayuki
Higashi Seiko
Eisai Co. Ltd.
Seaman D. Margaret
LandOfFree
Mono- or polyenic carboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mono- or polyenic carboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mono- or polyenic carboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-469302